1. Home
  2. RAPT vs BKN Comparison

RAPT vs BKN Comparison

Compare RAPT & BKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • BKN
  • Stock Information
  • Founded
  • RAPT 2015
  • BKN 1992
  • Country
  • RAPT United States
  • BKN United States
  • Employees
  • RAPT N/A
  • BKN N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • BKN Trusts Except Educational Religious and Charitable
  • Sector
  • RAPT Health Care
  • BKN Finance
  • Exchange
  • RAPT Nasdaq
  • BKN Nasdaq
  • Market Cap
  • RAPT 194.2M
  • BKN 196.1M
  • IPO Year
  • RAPT 2019
  • BKN N/A
  • Fundamental
  • Price
  • RAPT $26.62
  • BKN $11.31
  • Analyst Decision
  • RAPT Buy
  • BKN
  • Analyst Count
  • RAPT 6
  • BKN 0
  • Target Price
  • RAPT $34.17
  • BKN N/A
  • AVG Volume (30 Days)
  • RAPT 180.1K
  • BKN 55.5K
  • Earning Date
  • RAPT 11-11-2025
  • BKN 01-01-0001
  • Dividend Yield
  • RAPT N/A
  • BKN 4.38%
  • EPS Growth
  • RAPT N/A
  • BKN N/A
  • EPS
  • RAPT N/A
  • BKN N/A
  • Revenue
  • RAPT N/A
  • BKN N/A
  • Revenue This Year
  • RAPT N/A
  • BKN N/A
  • Revenue Next Year
  • RAPT N/A
  • BKN N/A
  • P/E Ratio
  • RAPT N/A
  • BKN N/A
  • Revenue Growth
  • RAPT N/A
  • BKN N/A
  • 52 Week Low
  • RAPT $5.67
  • BKN $9.57
  • 52 Week High
  • RAPT $27.74
  • BKN $12.69
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 89.76
  • BKN 65.75
  • Support Level
  • RAPT $18.08
  • BKN $11.30
  • Resistance Level
  • RAPT $21.29
  • BKN $11.43
  • Average True Range (ATR)
  • RAPT 1.91
  • BKN 0.07
  • MACD
  • RAPT 0.91
  • BKN -0.02
  • Stochastic Oscillator
  • RAPT 92.12
  • BKN 48.30

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About BKN BlackRock Investment Quality Municipal Trust Inc. (The)

Blackrock Investment Quality Municipal Trust, Inc. is a closed-end management investment fund with the investment objective to provide high current income exempt from regular U.S. federal income tax consistent with the preservation of capital.

Share on Social Networks: